» Articles » PMID: 34987703

Old and New Biomarkers Associated with Endothelial Dysfunction in Chronic Hyperglycemia

Overview
Publisher Wiley
Date 2022 Jan 6
PMID 34987703
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic hyperglycemia and vascular damage are strictly related. Biomarkers of vascular damage have been intensively studied in the recent years in the quest of reliable cardiovascular risk assessment tools able to facilitate risk stratification and early detection of vascular impairment. The present study is a narrative review with the aim of revising the available evidence on current and novel markers of hyperglycemia-induced vascular damage. After a discussion of classic tools used to investigate endothelial dysfunction, we provide an in-depth description of novel circulating biomarkers (chemokines, extracellular vesicles, and epigenetic and metabolomic biomarkers). Appropriate use of a single as well as a cluster of the discussed biomarkers might enable in a near future (a) the prompt identification of targeted and customized treatment strategies and (b) the follow-up of cardiovascular treatment efficacy over time in clinical research and/or in clinical practice.

Citing Articles

Editorial: Preventing cardiovascular complications of type 2 diabetes.

Baldassarre M, Paolucci T, Park K, Pipino C Front Endocrinol (Lausanne). 2024; 15:1473603.

PMID: 39184141 PMC: 11341443. DOI: 10.3389/fendo.2024.1473603.


Immunological Profile and Markers of Endothelial Dysfunction in Elderly Patients with Cognitive Impairments.

Goncharov N, Popova P, Kudryavtsev I, Golovkin A, Savitskaya I, Avdonin P Int J Mol Sci. 2024; 25(3).

PMID: 38339164 PMC: 10855959. DOI: 10.3390/ijms25031888.

References
1.
Carlomosti F, DAgostino M, Beji S, Torcinaro A, Rizzi R, Zaccagnini G . Oxidative Stress-Induced miR-200c Disrupts the Regulatory Loop Among SIRT1, FOXO1, and eNOS. Antioxid Redox Signal. 2016; 27(6):328-344. DOI: 10.1089/ars.2016.6643. View

2.
Napoli C, Benincasa G, Schiano C, Salvatore M . Differential epigenetic factors in the prediction of cardiovascular risk in diabetic patients. Eur Heart J Cardiovasc Pharmacother. 2019; 6(4):239-247. PMC: 7363021. DOI: 10.1093/ehjcvp/pvz062. View

3.
Boulanger C, Loyer X, Rautou P, Amabile N . Extracellular vesicles in coronary artery disease. Nat Rev Cardiol. 2017; 14(5):259-272. DOI: 10.1038/nrcardio.2017.7. View

4.
Rajasekar P, ONeill C, Eeles L, Stitt A, Medina R . Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications. J Diabetes Res. 2015; 2015:436879. PMC: 4464584. DOI: 10.1155/2015/436879. View

5.
Ghiadoni L, Faita F, Salvetti M, Cordiano C, Biggi A, Puato M . Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens. 2012; 30(7):1399-405. DOI: 10.1097/HJH.0b013e328353f222. View